iA Global Asset Management Inc. boosted its holdings in Danaher Corporation (NYSE:DHR – Free Report) by 250.9% during the 2nd quarter, HoldingsChannel.com reports. The institutional investor owned 421,023 shares of the conglomerate’s stock after acquiring an additional 301,028 shares during the quarter. Danaher makes up approximately 1.3% of iA Global Asset Management Inc.’s holdings, making the stock its 18th biggest holding. iA Global Asset Management Inc.’s holdings in Danaher were worth $83,169,000 as of its most recent SEC filing.
Several other large investors have also bought and sold shares of the business. Boyd Watterson Asset Management LLC OH boosted its stake in Danaher by 2.1% in the second quarter. Boyd Watterson Asset Management LLC OH now owns 2,524 shares of the conglomerate’s stock valued at $499,000 after buying an additional 51 shares in the last quarter. Worth Financial Advisory Group LLC boosted its stake in Danaher by 4.6% in the second quarter. Worth Financial Advisory Group LLC now owns 1,195 shares of the conglomerate’s stock valued at $236,000 after buying an additional 53 shares in the last quarter. 1834 Investment Advisors Co. boosted its stake in Danaher by 3.3% in the first quarter. 1834 Investment Advisors Co. now owns 1,666 shares of the conglomerate’s stock valued at $342,000 after buying an additional 54 shares in the last quarter. Bruce G. Allen Investments LLC boosted its stake in Danaher by 13.1% in the second quarter. Bruce G. Allen Investments LLC now owns 467 shares of the conglomerate’s stock valued at $92,000 after buying an additional 54 shares in the last quarter. Finally, Cassaday & Co Wealth Management LLC boosted its stake in Danaher by 1.2% in the first quarter. Cassaday & Co Wealth Management LLC now owns 4,717 shares of the conglomerate’s stock valued at $967,000 after buying an additional 56 shares in the last quarter. 79.05% of the stock is owned by institutional investors and hedge funds.
Insiders Place Their Bets
In other Danaher news, Director Teri List sold 2,778 shares of the business’s stock in a transaction on Friday, August 22nd. The stock was sold at an average price of $211.06, for a total value of $586,324.68. Following the transaction, the director owned 20,751 shares of the company’s stock, valued at approximately $4,379,706.06. The trade was a 11.81% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Corporate insiders own 11.10% of the company’s stock.
Danaher Trading Up 0.3%
Danaher (NYSE:DHR – Get Free Report) last released its quarterly earnings data on Tuesday, October 21st. The conglomerate reported $1.89 EPS for the quarter, beating the consensus estimate of $1.72 by $0.17. The firm had revenue of $6.05 billion during the quarter, compared to the consensus estimate of $6 billion. Danaher had a return on equity of 10.92% and a net margin of 14.44%.The company’s quarterly revenue was up 4.4% on a year-over-year basis. During the same quarter in the previous year, the company posted $1.71 earnings per share. Danaher has set its FY 2025 guidance at 7.700-7.800 EPS. Research analysts forecast that Danaher Corporation will post 7.63 earnings per share for the current year.
Danaher Dividend Announcement
The firm also recently disclosed a quarterly dividend, which was paid on Friday, October 31st. Shareholders of record on Friday, September 26th were given a $0.32 dividend. The ex-dividend date of this dividend was Friday, September 26th. This represents a $1.28 annualized dividend and a yield of 0.6%. Danaher’s payout ratio is currently 26.39%.
Wall Street Analysts Forecast Growth
A number of brokerages have recently commented on DHR. Rothschild Redb lowered Danaher from a “strong-buy” rating to a “hold” rating in a research note on Wednesday, October 8th. Bank of America cut their price target on Danaher from $230.00 to $220.00 and set a “buy” rating on the stock in a research note on Monday, September 22nd. Wells Fargo & Company reissued a “positive” rating on shares of Danaher in a research note on Thursday, October 23rd. Weiss Ratings reissued a “hold (c-)” rating on shares of Danaher in a research note on Wednesday, October 8th. Finally, Guggenheim reissued a “buy” rating and set a $250.00 price target on shares of Danaher in a research note on Wednesday, July 23rd. Eighteen research analysts have rated the stock with a Buy rating and five have issued a Hold rating to the company. According to MarketBeat, the company presently has an average rating of “Moderate Buy” and an average price target of $243.39.
View Our Latest Stock Analysis on Danaher
Danaher Profile
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.
Featured Stories
- Five stocks we like better than Danaher
- What is Insider Trading? What You Can Learn from Insider Trading
- Is Beyond Meat a Buy After Meme Stock Surge? Analysts Say No
- Differences Between Momentum Investing and Long Term Investing
- ABBV Stock: $250 May Be the New Floor After Big Q3 Earnings Beat
- Natural Gas Prices Continue To Rally, These Stocks Should Benefit
- Super Micro’s Moment of Truth: A Growth Story Under Pressure
Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Corporation (NYSE:DHR – Free Report).
Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.
